Warby Parker (WRBY) Competitors

$28.75 +0.26 (+0.91%)

As of 02:34 PM Eastern

WRBY vs. GKOS, BLCO, STVN, IRTC, and LIVN

Should you buy Warby Parker stock or one of its competitors? MarketBeat compares Warby Parker with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Warby Parker include Glaukos (GKOS), Bausch + Lomb (BLCO), Stevanato Group (STVN), iRhythm Technologies (IRTC), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

How does Warby Parker compare to Glaukos?

Glaukos (NYSE:GKOS) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

99.0% of Glaukos shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 5.8% of Glaukos shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Glaukos presently has a consensus price target of $144.42, suggesting a potential upside of 3.26%. Warby Parker has a consensus price target of $29.00, suggesting a potential upside of 0.88%. Given Glaukos' stronger consensus rating and higher possible upside, analysts clearly believe Glaukos is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glaukos	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

Glaukos has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, indicating that its share price is 95% more volatile than the broader market.

Warby Parker has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glaukos	$507.44M	16.19	-$187.69M	-$3.28	N/A
Warby Parker	$871.91M	3.53	$1.64M	$0.02	1,437.40

Warby Parker has a net margin of 0.15% compared to Glaukos' net margin of -34.34%. Warby Parker's return on equity of 2.30% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glaukos	-34.34%	-6.92%	-5.25%
Warby Parker	0.15%	2.30%	1.18%

In the previous week, Warby Parker had 15 more articles in the media than Glaukos. MarketBeat recorded 21 mentions for Warby Parker and 6 mentions for Glaukos. Warby Parker's average media sentiment score of 0.54 beat Glaukos' score of 0.14 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glaukos	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats Glaukos on 11 of the 17 factors compared between the two stocks.

How does Warby Parker compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

In the previous week, Warby Parker had 16 more articles in the media than Bausch + Lomb. MarketBeat recorded 21 mentions for Warby Parker and 5 mentions for Bausch + Lomb. Warby Parker's average media sentiment score of 0.54 beat Bausch + Lomb's score of 0.16 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Bausch + Lomb has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market.

Bausch + Lomb presently has a consensus price target of $18.08, suggesting a potential upside of 11.54%. Warby Parker has a consensus price target of $29.00, suggesting a potential upside of 0.88%. Given Bausch + Lomb's higher possible upside, equities research analysts clearly believe Bausch + Lomb is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

Warby Parker has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.13	-$360M	-$0.62	N/A
Warby Parker	$871.91M	3.53	$1.64M	$0.02	1,437.40

Warby Parker has a net margin of 0.15% compared to Bausch + Lomb's net margin of -4.21%. Bausch + Lomb's return on equity of 3.60% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-4.21%	3.60%	1.69%
Warby Parker	0.15%	2.30%	1.18%

Summary

Warby Parker beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Stevanato Group has higher revenue and earnings than Warby Parker. Stevanato Group is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	3.98	€158.21M	€0.59	29.89
Warby Parker	$871.91M	3.53	$1.64M	$0.02	1,437.40

Stevanato Group has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market.

Warby Parker has a consensus price target of $29.00, suggesting a potential upside of 0.88%. Given Warby Parker's stronger consensus rating and higher possible upside, analysts clearly believe Warby Parker is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

93.2% of Warby Parker shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Stevanato Group has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Stevanato Group's return on equity of 10.27% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Warby Parker	0.15%	2.30%	1.18%

In the previous week, Warby Parker had 13 more articles in the media than Stevanato Group. MarketBeat recorded 21 mentions for Warby Parker and 8 mentions for Stevanato Group. Warby Parker's average media sentiment score of 0.54 beat Stevanato Group's score of 0.15 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	0 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats Stevanato Group on 9 of the 16 factors compared between the two stocks.

How does Warby Parker compare to iRhythm Technologies?

Warby Parker (NYSE:WRBY) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Warby Parker has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$871.91M	3.53	$1.64M	$0.02	1,437.40
iRhythm Technologies	$787.85M	4.76	-$44.55M	-$0.86	N/A

Warby Parker has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market.

Warby Parker currently has a consensus price target of $29.00, suggesting a potential upside of 0.88%. iRhythm Technologies has a consensus price target of $193.38, suggesting a potential upside of 69.47%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93

93.2% of Warby Parker shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Warby Parker has a net margin of 0.15% compared to iRhythm Technologies' net margin of -3.53%. Warby Parker's return on equity of 2.30% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

In the previous week, Warby Parker had 16 more articles in the media than iRhythm Technologies. MarketBeat recorded 21 mentions for Warby Parker and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.47 beat Warby Parker's score of 0.54 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does Warby Parker compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

In the previous week, Warby Parker had 13 more articles in the media than LivaNova. MarketBeat recorded 21 mentions for Warby Parker and 8 mentions for LivaNova. LivaNova's average media sentiment score of 0.57 beat Warby Parker's score of 0.54 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Warby Parker	8 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a net margin of 7.48% compared to Warby Parker's net margin of 0.15%. LivaNova's return on equity of 16.48% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
Warby Parker	0.15%	2.30%	1.18%

LivaNova presently has a consensus target price of $77.22, suggesting a potential upside of 7.06%. Warby Parker has a consensus target price of $29.00, suggesting a potential upside of 0.88%. Given LivaNova's stronger consensus rating and higher possible upside, research analysts plainly believe LivaNova is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Warby Parker	0 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.63

97.6% of LivaNova shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 0.4% of LivaNova shares are owned by company insiders. Comparatively, 16.8% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

LivaNova has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market.

Warby Parker has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.43B	2.76	-$242.47M	$1.95	36.99
Warby Parker	$871.91M	3.53	$1.64M	$0.02	1,437.40

Summary

LivaNova beats Warby Parker on 9 of the 16 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WRBY vs. The Competition

Export

Metric	Warby Parker	CONS PD Industry	Staples Sector	NYSE Exchange
Market Cap	$3.08B	$30.20B	$16.21B	$22.99B
Dividend Yield	N/A	3.38%	3.49%	4.07%
P/E Ratio	1,438.22	78.20	23.21	28.42
Price / Sales	3.53	1.52	47.67	24.19
Price / Cash	42.83	30.87	16.36	25.11
Price / Book	8.19	11.45	5.27	4.75
Net Income	$1.64M	$1.33B	$674.08M	$1.06B
7 Day Performance	5.42%	-1.54%	-1.12%	-0.67%
1 Month Performance	24.29%	-1.98%	-1.59%	1.82%
1 Year Performance	64.93%	-17.20%	-11.65%	25.05%

Warby Parker Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WRBY Warby Parker	2.5974 of 5 stars	$28.75 +0.9%	$29.00 +0.9%	+54.0%	$3.08B	$871.91M	1,438.22	4,036	Earnings Report Analyst Upgrade Options Volume
GKOS Glaukos	2.632 of 5 stars	$135.17 +1.2%	$144.42 +6.8%	+48.8%	$7.84B	$507.44M	N/A	1,094	Insider Trade
BLCO Bausch + Lomb	4.3138 of 5 stars	$16.10 -0.5%	$18.08 +12.3%	+36.8%	$5.77B	$5.21B	N/A	13,000	News Coverage
STVN Stevanato Group	2.9967 of 5 stars	€18.29 +0.1%	N/A	-28.0%	€5.54B	€1.34B	31.00	6,010	Earnings Report Gap Up
IRTC iRhythm Technologies	4.3862 of 5 stars	$116.84 -3.2%	$193.38 +65.5%	-18.0%	$3.97B	$747.14M	N/A	2,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WRBY) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Warby Parker (WRBY) Competitors

WRBY vs. GKOS, BLCO, STVN, IRTC, and LIVN

How does Warby Parker compare to Glaukos?

Summary

How does Warby Parker compare to Bausch + Lomb?

Summary

How does Warby Parker compare to Stevanato Group?

Summary

How does Warby Parker compare to iRhythm Technologies?

Summary

How does Warby Parker compare to LivaNova?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WRBY vs. The Competition

Warby Parker Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Warby Parker (WRBY) Competitors

WRBY vs. GKOS, BLCO, STVN, IRTC, and LIVN

How does Warby Parker compare to Glaukos?

Do institutionals & insiders hold more shares of GKOS or WRBY?

Do analysts recommend GKOS or WRBY?

Which has more risk & volatility, GKOS or WRBY?

Which has preferable valuation and earnings, GKOS or WRBY?

Is GKOS or WRBY more profitable?

Does the media favor GKOS or WRBY?

Summary

How does Warby Parker compare to Bausch + Lomb?

Does the media favor BLCO or WRBY?

Do insiders and institutionals hold more shares of BLCO or WRBY?

Which has more volatility and risk, BLCO or WRBY?

Do analysts prefer BLCO or WRBY?

Which has better valuation & earnings, BLCO or WRBY?

Is BLCO or WRBY more profitable?

Summary

How does Warby Parker compare to Stevanato Group?

Which has better valuation & earnings, STVN or WRBY?

Which has more volatility and risk, STVN or WRBY?

Do analysts prefer STVN or WRBY?

Do insiders and institutionals hold more shares of STVN or WRBY?

Is STVN or WRBY more profitable?

Does the media favor STVN or WRBY?

Summary

How does Warby Parker compare to iRhythm Technologies?

Which has stronger earnings and valuation, WRBY or IRTC?

Which has more risk & volatility, WRBY or IRTC?

Do analysts rate WRBY or IRTC?

Do institutionals and insiders hold more shares of WRBY or IRTC?

Is WRBY or IRTC more profitable?

Does the media prefer WRBY or IRTC?

Summary

How does Warby Parker compare to LivaNova?

Does the media prefer LIVN or WRBY?

Is LIVN or WRBY more profitable?

Do analysts recommend LIVN or WRBY?

Do insiders & institutionals hold more shares of LIVN or WRBY?

Which has more volatility & risk, LIVN or WRBY?

Which has stronger valuation and earnings, LIVN or WRBY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WRBY vs. The Competition

Warby Parker Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools